The University of the Philippines Hydroxychloroquine PEP Against COVID-19 Trial

NCT04364815 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Investigators opted to change the design of the study.

Conditions

COVID-19

Interventions

DRUG: Hydroxychloroquine plus standard preventive measures
DRUG: Placebo plus standard preventive measures

Sponsor

University of the Philippines